Showing results (1581-1590 of 1,709) with videos related to
Sort By:
Pageof 171
Ultrasound Quarterly|November 30, 2011
ACR Appropriateness Criteria® assessment of gravid cervixPhyllis Glanc, Rochelle F Andreotti, Susanna I Lee, et al.The British Journal of Surgery|June 7, 2021
Analysis of trimodal and bimodal therapy in a selective-surgery paradigm for locally advanced oesophageal squamous cell carcinomaN Zhou, K G Mitchell, E M Corsini, et al.BMC Nursing|March 11, 2025
Mixed methods evaluation of a digital resource to build students' skills in ASsessing cardiovascular risk, MOtivating change, and SUStaining a healthier lifestyle in themselves and others- ASMOSUS: a study protocolL Creighton, G Caughers, G Thompson, et al.Msystems|August 7, 2023
The intestinal microbiota predicts COVID-19 severity and fatality regardless of hospital feeding methodVanni Bucci, Doyle V Ward, Shakti Bhattarai, et al.The Medical Journal of Australia|March 20, 2014
Increasing incidence of Clostridium difficile infection, Australia, 2011-2012Claudia Slimings, Paul Armstrong, Wendy D Beckingham, et al.Innovations (Philadelphia, Pa.)|December 27, 2019
Surveillance After Treatment of Non-Small-Cell Lung Cancer: A Call for Multidisciplinary StandardizationKyle G Mitchell, David B Nelson, Erin M Corsini, et al.Journal of Medical Genetics|May 18, 2010
The carrier clinic: an evaluation of a novel clinic dedicated to the follow-up of BRCA1 and BRCA2 carriers--implications for oncogenetics practiceE K Bancroft, I Locke, A Ardern-Jones, et al.Geophysical Research Letters|July 21, 2022
Closed Fluxtubes and Dispersive Proton Conics at Jupiter's Polar CapJ R Szalay, G Clark, G Livadiotis, et al.The Journal of Thoracic and Cardiovascular Surgery|August 24, 2023
Perioperative and oncologic outcomes of pulmonary resection for synchronous oligometastatic non-small cell lung cancer: Evidence for surgery in advanced diseaseNathaniel Deboever, Kyle G Mitchell, Ahsan Farooqi, et al.British Journal of Pharmacology|May 22, 2025
Casdatifan (AB521) is a novel and potent allosteric small molecule inhibitor of protumourigenic HIF-2α dependent transcriptionPatrick G Schweickert, Dana Piovesan, Casey G Mitchell, et al.Pageof 171